Acalabrutinib (Calquence) demonstrated efficacy and tolerability across multiple organs affected by steroid-refractory chronic graft-vs-host disease (cGVHD), according to primary findings from a ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical ...

Learn how the local Blood Cancer United chapter is partnering with Santé Health Foundation to support blood cancer research ...

When most people think of romantic mess and The Beatles, they usually recall the persistent — and false — rumor that John ...

AbbVie Inc. (NYSE:ABBV) Q4 2025 Earnings Call Transcript February 4, 2026 AbbVie Inc. beats earnings expectations. Reported ...

Eli Lilly and Company (NYSE:LLY) Q4 2025 Earnings Call Transcript February 4, 2026 Eli Lilly and Company beats earnings ...

New retrospective analysis showed Orca-T with reduced intensity conditioning (RIC) demonstrated favorable OS, RFS and GRFS compared to PTCyCompany announced first patients dosed in the Phase 2 ...

Explore the rich history of the Norton Museum of Art, from its 1941 opening as South Florida's first art museum to its ...

Bruton tyrosine kinase inhibitors (BTKis) are a cornerstone of chronic lymphocytic leukemia (CLL) therapy, with newer second-generation agents developed to maintain efficacy while improving ...

Researchers identified 30 modifiable factors that influence cancer risk, from smoking to sun exposure. More than a third of ...

Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and ...

Globally, smoking was the biggest risk factor for men, accounting for almost one-quarter of the 4.3 million preventable ...